YM928 is an orally active and noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist. YM928 inhibits AMPA receptor -mediated toxicity in primary rat hippocampal cultures with an IC 50 value of 2 μM. YM928 blocks AMPA-induced intracellular calcium influx with an IC 50 value of 3 μM and antagonizes AMPA-induced inward currents with an IC 50 value of 1 μM. YM928 is promising for research of neurological disorders.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > iGluR
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.